Clinical Trials on Individuals at Risk of Developing Diabetes in Hong Kong
Total 1 results
-
The University of Hong KongCompletedWomen at Risk of Common Mental DisordersHong Kong
Sponsors and Collaborators
- INESC TEC - Institute for Systems and Computer Engineering, Technology and Science (Porto, Portugal)
- Iran Ministry of Health, Treatment, and Medical Education
- Skin Laser & Surgery Specialists
- Meng Li
- North Tees and Hartlepool NHS Foundation Trust
- Child Medical Center, 3 Rue de la Prugne, 63540 Romagnat, France
- EULAR Lupus Nephritis Trial Network Study Group
- University of Crete Medical School - University Hospital of Heraklion
- Italian Academy of Rhinology
- Permanente Dental Associates Group, Oregon
- Azienda Sanitaria Locale N.1 dell'Umbria
- Emergency Medical Service Ostrava, Ostrava, Czech Republic
- Kevin W Hatton, MD, PhD
- Hospital of Southern Jutland
- Metiv Israel Psychotrauma Center
- Anthony Johnson
- Spital Linth
- Institute of Child Health, London, England
- Daily Centre for Psychiatry and Speech Disorders Poland
- Amy Farabaugh, PhD
- View Full List
Medical Conditions
- Post-micturition Incontinence
- Neuralgia, Postherpetic
- Metformin Concentration
- Thyroid Eye Disease
- Primary Lymphoma of the Central Nervous System
- Laxative Compatibility
- Relapsed/Refractory Large B-cell Lymphoma
- Sodium Selenite
- Mastoid Cavity
- Peripheral T-cell Lymphomas
- Tendon CSA
- Crystal Meth Addiction
- Leiomyomas
- Working Memory Training
- Exercise Intolerance, Riboflavin-Responsive
- Non-small Cell Lung Cancer Stage ⅢA
- Management of Lung Cancer Patients
- Peptic Ulcer With Haemorrhage
- Indirect Incentive
- Haematologic Disease
- View Full List
Drug Interventions
- Percutaneous sirolimus
- Anastrozole
- Vinorelbine tartrate
- Tranexamic acid
- Modified Bolus 5-FU/LV with Irinotecan
- 6-Mercaptopurine
- Amisulpride Oral Tablet
- PCO371
- Cetuximab
- 5.0g SRT501
- Visanne (Dienogest, BAY86-5258)
- Granulocyte colony-stimulating factor
- Ketamine 0.3 mg/kg at anesthesia induction
- Sodium Nitroprusside
- Tenofovir
- Follitropin beta liquid formulation
- Sipuleucel-T
- 30 mg CVL-231 as slow-release MR formulation
- Nicoderm C-Q Transdermal Product
- Trastuzumab in combination with SubQ GM-CSF
- View Full List
CROs by country
- Contract Research Organizations in Australia
- Contract Research Organizations in Burkina Faso
- Contract Research Organizations in Cote d'Ivoire
- Contract Research Organizations in Denmark
- Contract Research Organizations in Guinea
- Contract Research Organizations in Indonesia
- Contract Research Organizations in Iran
- Contract Research Organizations in Jamaica
- Contract Research Organizations in Moldova
- Contract Research Organizations in Montenegro
- Contract Research Organizations in Myanmar
- Contract Research Organizations in Suriname
- Contract Research Organizations in Vietnam
- CRO list by country